Contact
searchSearch
HMP Global
Login
Quiz

Self-Reported Rates of Illicitly Manufactured Fentanyl Use

Maria Mantas
06/11/2025

Related Content

NYSAM 2026 Meeting Logo
Conference Coverage
NYSAM 2026 Spotlights Harm Reduction, Psychiatric Care in SUD Treatment
03/17/2026
Brionna Mendoza
At the 2026 New York Society of Addiction Medicine (NYSAM) Annual Conference in New York, clinicians and policymakers focused on integrating evolving policy with patient-centered addiction care.
At the 2026 New York Society of Addiction Medicine (NYSAM) Annual Conference in New York, clinicians and policymakers focused on integrating evolving policy with patient-centered addiction care.
At the 2026 New York Society of...
03/17/2026
Psych Congress Network
Evguenia Makovkina, MD
Conference Coverage
Education Intervention Boosts Psychiatrists’ Knowledge and Attitudes on mOUD
03/07/2026
Evguenia Makovkina, MD
Evguenia Makovkina, MD, discusses key findings from her pilot study examining psychiatrists’ baseline knowledge, attitudes, and prescribing practices related to medications for opioid use disorder (mOUD).
Evguenia Makovkina, MD, discusses key findings from her pilot study examining psychiatrists’ baseline knowledge, attitudes, and prescribing practices related to medications for opioid use disorder (mOUD).
Evguenia Makovkina, MD,...
03/07/2026
Psych Congress Network
pills spilling out of a tipped over pill bottle
News
Health Plan Disenrollment After MOUD Initiation Tied to Higher Mortality in US Cohort
03/05/2026
Maria Mantas
Health plan disenrollment after initiation of medications for opioid use disorder (MOUD) was associated with significantly increased all-cause and overdose mortality in a recent cohort study.
Health plan disenrollment after initiation of medications for opioid use disorder (MOUD) was associated with significantly increased all-cause and overdose mortality in a recent cohort study.
Health plan disenrollment after...
03/05/2026
Psych Congress Network
A presentation at the Rx and Illicit Drug Summit
Press Release
ONDCP Director Sara Carter, CNN’s Sanjay Gupta to Headline HMP Global’s 15th Anniversary Rx Summit
02/26/2026
Held April 6-9 in Nashville, the event equips clinicians, policymakers, and public safety leaders with strategies to address nitazenes, trafficking, and pain management.
Held April 6-9 in Nashville, the event equips clinicians, policymakers, and public safety leaders with strategies to address nitazenes, trafficking, and pain management.
Held April 6-9 in Nashville, the...
02/26/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Desiree Matthews, PHMNP-BC; Amber Hoberg, MSN, APRN, PMHNP-BC
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use